Press Release | NeoGenomics Laboratories

October 23, 2018

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

October 1, 2018

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

September 24, 2018

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

September 12, 2018

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

August 24, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock

August 9, 2018

NeoGenomics Announces Pricing on Public Offering of Common Stock

August 6, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock

July 24, 2018

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients